Speakers

Krishnan Viswanadhan

President and Chief Operating Officer • Be Biopharma

Dr. Krishnan Viswanadhan is a biopharmaceutical executive with over 20 years of broad cross-functional experience in advancing new medicines for patients with serious and life-threatening diseases. Krishnan is currently President and Chief Operating Officer at Be Biopharma, a leader in engineered B cells as a new category of medicines for patients with serious diseases.

Prior to Be Bio, Krishnan was Senior Vice President, Global Cell Therapy Franchise Lead at Bristol Myers Squibb where he was responsible for overseeing the integrated cell therapy franchise strategy across the enterprise including building core capabilities and key investments to support long term growth. He oversaw the teams responsible for the development, approval, and life cycle management of Breyanzi, a CD19 CAR T and Abecma, the first BCMA CAR T therapy.

Prior to BMS, Krishnan was Vice President, Business Development and Global Alliances at Celgene Corporation responsible for managing the portfolio of partnerships and equity investments. Prior to Celgene, Krishnan had roles in large and small companies in regulatory strategy.

Dr. Viswanadhan is a registered Pharmacist and received his Doctor of Pharmacy degree from Rutgers University and holds a Master of Business Administration degree from Cornell University.

 

Krishnan currently serves the board as a non-executive director of JW Therapeutics, a leading cell therapy company in China.

 

Also Speaking

Daniel C. Smith

Executive Director, Global Cell & Gene Therapy Portfolio • Charles River

Hanna Lesch

Chief Technology Officer • Exothera

Maria Croyle

Professor of Molecular Pharmaceutics and Drug Delivery/Glaxo Wellcome Professor • University of Texas at Austin

Event Info

Image

Fun Run